Sumitomo Pharma Co Ltd

XMUN:DPM

Business Description

Sector

Health Care

Industry

Pharmaceuticals

Headquarters

Japan JP

Employees

3 832

IPO date

May 16, 1949

Sumitomo Pharma is a Japanese drug company that develops, makes, and sells prescription medicines. Its business centers on medicines for patients with conditions such as mental health disorders, cancer, diabetes, Parkinson’s disease, and urology-related illnesses. It also works on drug discovery and clinical development, which means it spends money to find new medicines, test them, and bring them to market.

The company sells mainly to hospitals, clinics, doctors, pharmacies, and government health systems rather than to individual consumers. It earns money by selling branded prescription drugs and, in some cases, through licensing and partnerships around its research. Because prescription medicines must be approved by regulators and chosen by physicians, the company’s success depends on medical evidence, patent protection, and relationships with healthcare providers.

What makes Sumitomo Pharma different is that it is a research-driven pharmaceutical maker with a strong focus on specialty treatments, not a mass-market consumer health company. Its role in the healthcare chain is to turn laboratory research into regulated medicines and then supply those drugs to the medical system. That gives it a business model built around long development cycles, patent-backed products, and continued need for new therapies as older drugs lose protection.